Prijeđi na sadržaj

Lafutidin

Izvor: Wikipedija
Datum izmjene: 8. aprila 2014. u 08:20; autor: Dcirovicbot (razgovor | doprinosi) (.)
Lafutidin
(IUPAC) ime
2-[(2-furilmetil)sulfinil]-N-((2Z)-4[4-(piperidin-1-ilmetil)piridin-2-il]oksi}but-2-en-1-il)acetamid
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 118288-08-7
ATC kod A02BA08
PubChem[1][2] 5282136
UNII 49S4O7ADLC DaY
KEGG[3] D01131 DaY
Hemijski podaci
Formula C22H29N3O4S 
Mol. masa 431,54 g/mol
Farmakoinformacioni podaci
Trudnoća ?
Pravni status
Način primene Oralno

Lafutidin (INN) je antagonist H2 receptora.[4][5]

Reference

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  4. Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7. 
  5. Pdr Staff (2009). PDR: Physicians Desk Reference 2010 (Physicians' Desk Reference (Pdr)). Rozelle, N.S.W: Thomson Reuters. ISBN 1-56363-748-0. 

Literatura

Spoljašnje veze

Šablon:Medicinsko upozorenje-lat